🇺🇸 FDA
Patent

US 7285383

Method for selective inactivation of viral replication

granted A61KA61K48/00

Quick answer

US patent 7285383 (Method for selective inactivation of viral replication) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
62
CPC classes
A61K, A61K48/00